デフォルト表紙
市場調査レポート
商品コード
1672779

研究用抗体市場:製品タイプ別、形態別、用途別、エンドユーザー別、地域別

Research Antibodies Market, By Product Type, By Form, By Application, By End User, By Geography


出版日
ページ情報
英文 249 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
研究用抗体市場:製品タイプ別、形態別、用途別、エンドユーザー別、地域別
出版日: 2025年02月20日
発行: Coherent Market Insights
ページ情報: 英文 249 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の研究用抗体市場は、2025年には127億2,000万米ドルと推定され、2032年には201億7,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR6.8%で成長すると予測されています。

レポート範囲 レポート詳細
基準年 2024 2025年の市場規模 127億2,000万米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間:2025年~2032年 CAGR: 6.80% 2032年の価値予測 201億7,000万米ドル
図.研究用抗体市場シェア(%), 2025年地域別
Research Antibodies Market-IMG1

世界の研究用抗体市場は、製薬会社やバイオテクノロジー企業、学術機関、受託研究機関など、さまざまな最終用途分野での抗体採用の増加により、過去数年間で大きな成長を遂げています。研究用抗体は、医薬品開発プロセスや疾病診断手順において不可欠なツールとして広く使用されています。また、基礎科学研究や臨床研究においても重要な役割を果たしています。プロテオミクスやがん研究への投資の増加が、研究用抗体の需要を押し上げています。抗体工学と生産における技術の進歩は、その応用範囲をさらに広げています。世界の研究用抗体市場は、個別化医療への需要の高まりにより成長が見込まれています。

市場力学:

世界の研究用抗体市場の成長は、主に世界中で慢性疾患や感染症が増加していることが背景にあります。複雑な疾患の迅速な診断と新規生物製剤の開発が、製薬分野における研究用抗体の需要を押し上げています。プロテオミクスや細胞ベースの研究活動に対する民間および公的機関による投資の増加は、市場プレイヤーに有利な機会を提供する可能性があります。しかし、抗体作製に関連する高コストや、抗体認可のための厳しい規制基準が市場成長の妨げとなる可能性があります。完全ヒトモノクローナル抗体の開発と高度な抗体作製技術の採用は、近い将来、市場関係者に成長機会を提供すると期待されています。

本調査の主な特徴

  • この調査レポートは、世界の研究用抗体市場を詳細に分析し、2024年を基準年とした予測期間(2025-2032年)の市場規模および複合年間成長率(CAGR%)を掲載しています。
  • さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の研究用抗体市場の主要企業をプロファイルしています。
  • 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • 研究用抗体の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
  • 利害関係者は、世界の研究用抗体市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map(COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 影響分析
  • 市場動向
  • 主な発展
  • 規制シナリオ
  • 買収と提携のシナリオ
  • 資金調達と投資
  • PEST分析
  • ポーターの分析

第4章 世界の研究用抗体市場- コロナウイルス(COVID-19)パンデミックの影響

  • 全体的な影響
  • 政府の取り組み
  • COVID-19による市場への影響

第5章 世界の研究用抗体市場、製品タイプ別、2020年-2032年、(10億米ドル)

  • 一次抗体
  • 二次抗体
  • 試薬
  • 消耗品

第6章 世界の研究用抗体市場、形態別、2020年-2032年、(10億米ドル)

  • モノクローナル抗体
  • ポリクローナル抗体
  • 組み換え抗体

第7章 世界の研究用抗体市場、用途別、2020年-2032年、(10億米ドル)

  • ウエスタンブロッティング
  • ELISA
  • フローサイトメトリー
  • 免疫細胞化学(ICC)/免疫蛍光(IF)
  • 免疫組織化学(IHC)
  • その他(免疫沈降法、マルチプレックス免疫吸着法など)

第8章 世界の研究用抗体市場、エンドユーザー別、2020年-2032年、(10億米ドル)

  • 学術研究機関
  • 受託研究機関
  • 製薬・バイオテクノロジー企業

第9章 世界の研究用抗体市場、地域別、2020年-2032年、(10億米ドル)

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第10章 競合情勢

  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA(including Sigma-Aldrich)
    • Abcam plc
    • Cell Signaling Technology, Inc.
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Lonza Group AG
    • GenScript Biotech Corporation
    • BioLegend, Inc.
    • Bio-Techne Corporation
    • F. Hoffmann-La Roche Ltd
    • Santa Cruz Biotechnology, Inc.
    • BD Biosciences(Becton, Dickinson and Company)
    • PerkinElmer, Inc.
    • Active Motif
    • QIAGEN NV
    • OriGene Technologies, Inc.
    • Jackson ImmunoResearch Laboratories, Inc.
    • R&D Systems(part of Bio-Teachne Corporation)
    • Proteintech Group, Inc.
  • 機会
  • アナリストの見解
  • Coherent Opportunity Map

第11章 参考文献と調査手法

  • 参考文献
  • 調査手法
目次
Product Code: CMI5247

Global Research Antibodies Market is estimated to be valued at USD 12.72 Bn in 2025 and is expected to reach USD 20.17 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 12.72 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.80% 2032 Value Projection: USD 20.17 Bn
Figure. Research Antibodies Market Share (%), By Region 2025
Research Antibodies Market - IMG1

Global research antibodies market has been witnessing significant growth over the past few years, owing to increasing adoption of antibodies across various end-use sectors including pharmaceutical and biotechnology companies, academic institutes, contract research organizations, and others. Research antibodies are widely used as indispensable tools in drug development processes and disease diagnosis procedures. These also play a vital role in basic science research and clinical discovery. Increasing investments in proteomics and cancer research have boosted demand for research antibodies. Technological advancements in antibody engineering and production further expand the scope of their applications. Global research antibodies market is expected to witness growth due to growing demand for personalized medicine.

Market Dynamics:

Global research antibodies market growth is primarily driven by increasing prevalence of chronic and infectious diseases worldwide. Rapid diagnosis of complex disorders and development of novel biologics boosts e demand for research antibodies in the pharmaceutical sector. Rising investments by private and public organizations in proteomics and cell-based research activities can offer lucrative opportunities for market players. However, high costs associated with antibody production and stringent regulatory norms for their approval can hamper the market growth. The development of fully human monoclonal antibodies and adoption of advanced antibody production technologies are expected to offer growth opportunities for the market players in the near future.

Key Features of the Study:

  • This report provides in-depth analysis of the global research antibodies market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global research antibodies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Abcam PLC, Merck Group, Bio-Rad Laboratories, Cell Signaling Technology, F. Hoffmann-La Roche Ltd, Agilent Technologies, and Danaher Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global research antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global research antibodies market.

Detailed Segmentation:

  • By Product Type:
    • Primary Antibodies
    • Secondary Antibodies
    • Reagents
    • Consumables
  • By Form
    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies
  • By Application
    • Western Blotting
    • ELISA
    • Flow Cytometry
    • Immunocytochemistry (ICC)/ Immunofluorescence (IF)
    • Immunohistochemistry (IHC)
    • Others (Immunoprecipitation, Multiplex Immunosorbent Assay and etc.)
  • By End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA (including Sigma-Aldrich)
    • Abcam plc
    • Cell Signaling Technology, Inc.
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Lonza Group AG
    • GenScript Biotech Corporation
    • BioLegend, Inc.
    • Bio-Techne Corporation
    • Hoffmann-La Roche Ltd
    • Santa Cruz Biotechnology, Inc.
    • BD Biosciences (Becton, Dickinson and Company)
    • PerkinElmer, Inc.
    • Active Motif
    • QIAGEN N.V.
    • OriGene Technologies, Inc.
    • Jackson ImmunoResearch Laboratories, Inc.
    • R&D Systems (part of Bio-Teachne Corporation)
    • Proteintech Group, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Form
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Research Antibodies Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Research Antibodies Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Primary Antibodies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Secondary Antibodies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Reagents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Consumables
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Research Antibodies Market, By Form, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Monoclonal Antibodies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Polyclonal Antibodies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Recombinant Antibodies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Research Antibodies Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Western Blotting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • ELISA
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Flow Cytometry
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immunocytochemistry (ICC)/ Immunofluorescence (IF)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immunohistochemistry (IHC)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Immunoprecipitation, Multiplex Immunosorbent Assay and etc.)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Research Antibodies Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Academic & Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pharmaceutical & Biotechnology Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Research Antibodies Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck KGaA (including Sigma-Aldrich)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abcam plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cell Signaling Technology, Inc.
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Lonza Group AG
    • GenScript Biotech Corporation
    • BioLegend, Inc.
    • Bio-Techne Corporation
    • F. Hoffmann-La Roche Ltd
    • Santa Cruz Biotechnology, Inc.
    • BD Biosciences (Becton, Dickinson and Company)
    • PerkinElmer, Inc.
    • Active Motif
    • QIAGEN N.V.
    • OriGene Technologies, Inc.
    • Jackson ImmunoResearch Laboratories, Inc.
    • R&D Systems (part of Bio-Teachne Corporation)
    • Proteintech Group, Inc.
  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact